EDITORIALS |

Oxleas NHS Foundation Trust, Pinewood House, Pinewood Place, Dartford, Kent DA2 7WG, UK. Email: carol.paton{at}oxleas.nhs.uk
In the past 3 years C.P. has acted as a consultant to companies that market antipsychotic and antidepressant medicines, and has contributed to the development of several National Institute for Health and Clinical Excellence guidelines.
Carol Paton (pictured) is chief pharmacist at Oxleas NHS Trust, joint-head of the Prescribing Observatory for Mental Health and an honorary research fellow at the Department of Psychological Medicine, Imperial College London.
See pp.
333–350, this
issue.
Psychotropic drugs reduce morbidity and mortality related to maternal mental illness but may also cause harm to the foetus, the nature and magnitude of which is not completely understood. Up-to-date information should be shared as fully as possible with the pregnant woman and a treatment plan agreed jointly.
Related articles in BJP:
This article has been cited by other articles:
![]() |
S. Gentile Antipsychotic Therapy During Early and Late Pregnancy. A Systematic Review Schizophr Bull, September 11, 2008; (2008) sbn107v1. [Abstract] [Full Text] [PDF] |
||||